A Patient with GOLD Stage 3 COPD « cured » by One-Way Endobronchial Valves
AbstractLung hyperinflation is a main determinant of dyspnoea in patients with chronic obstructive pulmonary disease (COPD). Surgical or bronchoscopic lung volume reduction are the most efficient therapeutic approaches for reducing hyperinflation in selected patients with emphysema. We here report the case of a 69-year old woman with COPD (GOLD stage 3-D) referred for lung volume reduction. She complained of persistent disabling dyspnoea despite appropriate therapy. Chest imaging showed marked emphysema heterogeneity as well as severe hyperinflation of the right lower lobe. She was deemed to be a good candidate for bronchoscopic treatment with one-way endobronchial valves. In the absence of interlobar collateral ventilation, 2 endobronchial valves were placed in the right lower lobe under general anaesthesia. The improvement observed 1 and 3 months after the procedure was such that the patient no longer met the pulmonary function criteria for COPD. The benefit persisted after 3 years. View Full-Text
Share & Cite This Article
Marchand, E.; d'Odemont, J.-P.; Dupont, M.V. A Patient with GOLD Stage 3 COPD « cured » by One-Way Endobronchial Valves. Medicina 2019, 55, 65.
Marchand E, d'Odemont J-P, Dupont MV. A Patient with GOLD Stage 3 COPD « cured » by One-Way Endobronchial Valves. Medicina. 2019; 55(3):65.Chicago/Turabian Style
Marchand, Eric; d'Odemont, Jean-Paul; Dupont, Michael V. 2019. "A Patient with GOLD Stage 3 COPD « cured » by One-Way Endobronchial Valves." Medicina 55, no. 3: 65.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.